Read + Share
Rosebrock AP. DNA Cross-Reactivity of the CDC-Specified SARS-CoV-2 Specimen Control Leads to
Potential for False Negatives and Underreporting of Viral Infection. Clin Chem 2020 Dec 12. pii: 5958118. doi: 10.1093.
PMID: 33313692
|
 |
|
Rosebrock AP. DNA Cross-Reactivity of the CDC-Specified SARS-CoV-2 Specimen Control Leads to
Potential for False Negatives and Underreporting of Viral Infection. Clin Chem 2020 Dec 12. pii: 5958118. doi: 10.1093.
PMID: 33313692
|
|
|
|